To access the full text documents, please follow this link: http://hdl.handle.net/2445/125750
dc.contributor.author | Moran, Sebastian |
---|---|
dc.contributor.author | Martínez Cardús, Anna |
dc.contributor.author | Boussios, S. |
dc.contributor.author | Esteller, Manel |
dc.date | 2018-10-30T14:20:01Z |
dc.date | 2018-10-30T14:20:01Z |
dc.date | 2017-07-04 |
dc.date | 2018-10-30T14:20:01Z |
dc.identifier.citation | 1759-4774 |
dc.identifier.citation | 673531 |
dc.identifier.uri | http://hdl.handle.net/2445/125750 |
dc.format | 35 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Nature Publishing Group |
dc.relation | Versió postprint del document publicat a: https://doi.org/10.1038/nrclinonc.2017.97 |
dc.relation | Nature Reviews Clinical Oncology, 2017, vol. 14, num. 11, p. 682 -694 |
dc.relation | https://doi.org/10.1038/nrclinonc.2017.97 |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/727264 /EU//EPIPHARM |
dc.rights | (c) Moran, S. et al., 2017 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Càncer |
dc.subject | Epigenètica |
dc.subject | Marcadors bioquímics |
dc.subject | Cancer |
dc.subject | Epigenetics |
dc.subject | Biochemical markers |
dc.title | Precision medicine based in epigenomics: the paradigm of carcinoma of unknown primary |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |